Anti-metabolic syndrome effects of adenosine ingestion in stroke-prone spontaneously hypertensive rats fed a high-fat diet

British Journal of Nutrition

Volumn 104, Issue 1, 2010, Pages 48-55

  Ardiansyah, ^a   Shirakawa, Hitoshi ^a   Sugita, Yumi ^a   Koseki, Takuya ^b   Komai, Michio ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Blood pressure; Glucose metabolism; High fat diet; Lipid profile

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADENOSINE; ADENOSINE RECEPTOR; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CASEIN; CELLULOSE; CHOLINE BITARTRATE; CYSTEINE; GLUCOSE; INSULIN; LARD; LIPID; MESSENGER RNA; MINERAL; NITRIC OXIDE; STARCH; SUCROSE; TARTARIC ACID DERIVATIVE; TERT BUTYLHYDROQUINONE; UNCLASSIFIED DRUG; VITAMIN MIXTURE; WATER; 8-HYDROXY-2'-DEOXYGUANOSINE; ADIPONECTIN RECEPTOR; ANTIOXIDANT; CARDIOVASCULAR AGENT; DEOXYGUANOSINE; DRUG DERIVATIVE; ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LIPID BLOOD LEVEL; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; ADIPOSE TISSUE; ANIMAL; BLOOD; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HYPERTENSION; KIDNEY; LIVER; METABOLISM; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; URINE;

RATTUS;

ADENOSINE; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CARDIOVASCULAR AGENTS; DEOXYGUANOSINE; DIETARY FATS; ENZYMES; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERTENSION; INSULIN; KIDNEY; LIPIDS; LIVER; MALE; METABOLIC SYNDROME X; NITRIC OXIDE; RATS; RATS, INBRED SHR; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; STROKE;

EID: 77954670603     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510000255     Document Type: Article

References (42)

1. Haffner S & Taegtmeyer H (2003) Epidemic obesity and the metabolic syndrome. Circulation 108, 1541-1545.
2. Sharma AM (2006) The obese patient with diabetes mellitus: from research targets to treatment options. Am J Med 119, 17-23.
3. Hardus PM, van Vuuren CL, Crawford D, et al. (2003) Public health perceptions of the causes and prevention of obesity among primary school children. Int J Obes Relat Metab Disord 27, 1465-1471.
4. Jackson EK & Dubey RK (2001) Role of the extracellular cAMP-adenosine pathway in renal physiology. Am J Physiol 28, F597-F612.
5. Olah SN & Stiles GL (2000) The role receptor structure in determining adenosine receptor activity. Pharmacol Ther 85, 55-75.
6. Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362, 299-309.
7. Fukumori Y, Maeda N, Takeda H, et al. (2000) Serum glucose and insulin response in rats administered with sucrose or starch containing adenosine, inosine or cytosine. Biosci Biotechnol Biochem 64, 237-243.
8. Fukumori Y, Takeda H, Fujisawa T, et al. (2000) Blood glucose and insulin concentrations are reduced in human administered sucrose with inosine or adenosine. J Nutr 130, 1946-1949.
9. Motti A, Tissot C, Rimensberger PC, et al. (2006) Intravenous adenosine for refractory pulmonary hypertension in low-weight premature newborn: a potential new drug for rescue therapy. Pediatr Crit Care Med 7, 380-382.
10. 2B receptors. Hypertension 46, 628-634.
11. Ardiansyah, Shirakawa H, Shimeno T, et al. (2009) Adenosine, an identified active component from the Driselase-treated fraction of rice bran, is effective at improving metabolic syndrome in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 57, 2558-2564.
12. Chan ES, Montesinos MC, Fernandez P, et al. (2006) Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 148, 1144-1155.
13. Peng Z, Fernandez P, Wilder T, et al. (2008) Ecto-5i-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 22, 2263-2272. (Pubitemid 351948645)
14. Dhalla AK, Wong MY, Voshol PJ, et al. (2007) A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents. Am J Physiol Endocrinol Metab 292, E1358-E1363.
15. Ardiansyah, Shirakawa H, Koseki T, et al. (2006) Rice bran fractions improve blood pressure, lipid profile, and glucose metabolism in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 54, 1914-1920.
16. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
17. Folch J, Lees M & Stanley GHS (1957) A simple method for the isolation and purification of total lipid from animal tissues. J Biol Chem 226, 497-509.
18. Wolever TM & Jenkins DJ (1986) The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr 43, 167-172.
19. Shirakawa H, Ohsaki Y, Minegishi Y, et al. (2006) Vitamin K deficiency reduces testosterone production in the testis through down-regulation of the Cyp11a a cholesterol side chain cleavage enzyme in rats. Biochim Biophys Acta 1760, 1482-1488.
20. Aitman TJ, Gotoda T, Evans AL, et al. (1997) Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet 16, 197-201.
21. Collison M, Glazier AM, Graham D, et al. (2000) Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 49, 2222-2226.
22. Hershfield MS (2005) New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur J Immunol 35, 25-30.
23. Kibbe M, Billiar T & Tzeng E (1999) Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 43, 650-657. (Pubitemid 29369263)
24. Moncada S, Higgs E & Palmer RMJ (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43, 109-142.
25. Malinski T, Kapturczak M, Dayharsh J, et al. (1993) Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 194, 654-658.
26. Fullerton DA, Agrafojo J & McIntyre RC Jr (1996) Pulmonory vascular smooth muscle relaxation by cAMP-mediated pathways. J Surg Res 61, 444-448.
27. Guinzberg R, Laguna I, Zentella A, et al. (1987) Effect of adenosine and inosine on ureagenesis in hepatocytes. Biochem J 245, 371-374.
28. \+. Biochem Biophys Res Commun 197, 229-234.
29. Tinton SA, Lefebvre VH, Cousin OC, et al. (1993) Cytolytic effects and biochemical changes induced by extracellular ATP to isolated hepatocytes. Biochim Biophys Acta 1176, 1-6.
30. 2\+ and cAMP. Eur J Pharmacol 437, 105-111.
31. Muroyama K, Murosaki S, Yamamoto Y, et al. (2003) Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice. J Nutr Sci Vitaminol 49, 56-63.
32. Murosaki S, Lee TL, Muroyama K, et al. (2007) A combination of caffeine, arginine, soy isoflavones, and L-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J Nutr 137, 2252-2257.
33. Peng Z, Borea PA, Varani K, et al. (2009) Adenosine signaling contributes to ethanol-induces fatty liver in mice. J Clin Invest 119, 582-594.
34. Kanaya Y, Doi T, Sasaki H, et al. (2004) Rice bran extract prevent the elevation of plasma peroxylipid in KKAy diabetic mice. Diabetes Metab Res Rev 66S, S157-S160.
35. Hsieh RH, Lien LM, Lin SH, et al. (2005) Alleviation of oxidative damage in multiple tissues in rats with streptozoto-cin-induced diabetes by rice bran oil supplementation. Ann N Y Acad Sci 1042, 365-371.
36. Friedman JM (2000) Obesity in the new millennium. Nature 404, 632-634.
37. Kim JY, van de Wall E, Laplante M, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117, 2621-2637.
38. Silver DL, Jiang XC & Tall AR (1999) Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice: possible role of leptin in stimulation of HDL turnover. J Biol Chem 274, 4140-4146.
39. Lundasen T, Liao W, Angelin B, et al. (2003) Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J Biol Chem 278, 43224-43228.
40. Gruen ML, Plummer MR, Zhang W, et al. (2005) Persistence of high density lipoprotein particles in obese mice lacking apolipo-protein A-I. J Lipid Res 46, 2007-2014.
41. Kadowaki T, Yamauchi T, Kubota N, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-1792.
42. Yamauchi T, Kamon J, Waki H, et al. (2001) The fat-derived hormone adiponectin reverse insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941-946.